Cargando…

Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA

BACKGROUND: Several non-invasive prediction scores for non-alcoholic fatty liver disease (NAFLD) have been developed, but their performance has not been compared and validated in the same population, and whether these prediction scores can predict clinical outcomes remains unknown. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheung, Ching-Lung, Lam, Karen SL, Wong, Ian CK, Cheung, Bernard MY
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207316/ https://www.ncbi.nlm.nih.gov/pubmed/25204761 http://dx.doi.org/10.1186/s12916-014-0154-x

Ejemplares similares

Non‐alcoholic fatty liver disease and type 2 diabetes: An update
por: Lee, Chi‐H, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease later diagnosed as myotonic dystrophy
por: Tanaka, Naoki, et al.
Publicado: (2020)

Association Between Low Muscle Mass and Non-alcoholic Fatty Liver Disease Diagnosed Using Ultrasonography, Magnetic Resonance Imaging Derived Proton Density Fat Fraction, and Comprehensive NAFLD Score in Korea
por: Lee, Hun Ju, et al.
Publicado: (2021)

Managing non‐alcoholic fatty liver disease in diabetes: Challenges and opportunities
por: Lee, Chi‐Ho, et al.
Publicado: (2016)

Utilization of Food-Derived β-Glucans to Prevent and Treat Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kei, Nelson, et al.
Publicado: (2023)

Underestimation of metabolic unhealthiness and overestimation of non-alcoholic fatty liver disease
por: Sarathi, Vijaya, et al.
Publicado: (2023)

Accuracy of Ultrasonography vs. Elastography in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review
por: Geethakumari, Prabhitha, et al.
Publicado: (2022)

A Retrospective Study of Hospitalizations in the USA: Proportion of Hospitalizations With Non-Alcoholic Fatty Liver Disease in Non-Obese Population
por: Oladunjoye, Olubunmi, et al.
Publicado: (2021)

Transcriptional and Epigenetic Alterations in the Progression of Non-Alcoholic Fatty Liver Disease and Biomarkers Helping to Diagnose Non-Alcoholic Steatohepatitis
por: Zhu, Yalan, et al.
Publicado: (2023)

Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients
por: Ng, Lui, et al.
Publicado: (2023)

Screening strategy for non-alcoholic fatty liver disease
por: Zhang, Saisai, et al.
Publicado: (2023)

Non-invasive tests of non-alcoholic fatty liver disease
por: Li, Guanlin, et al.
Publicado: (2022)

An analysis of polygenic risk scores for non-alcoholic fatty liver disease
por: Jun, Dae Won
Publicado: (2021)

Non-traumatic Retinal Detachment Diagnosed via Bedside Ultrasonography
por: Roka, Abhishek, et al.
Publicado: (2018)

Influence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease
por: Xia, Ming-Feng, et al.
Publicado: (2016)

External validation of non-invasive prediction models for identifying ultrasonography-diagnosed fatty liver disease in a Chinese population
por: Shen, Ya-Nan, et al.
Publicado: (2017)

The association of healthy lifestyle score and risk of non-alcoholic fatty liver disease
por: Jahromi, Mitra Kazemi, et al.
Publicado: (2023)

Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity
por: Drolz, Andreas, et al.
Publicado: (2021)

Serum biomarkers combined with ultrasonography for early diagnosis of non-alcoholic fatty liver disease confirmed by magnetic resonance spectroscopy
por: Qian, Ling-ling, et al.
Publicado: (2019)

Obesity as the common soil of non‐alcoholic fatty liver disease and diabetes: Role of adipokines
por: Hui, Elaine, et al.
Publicado: (2013)

Ultrasonography Greatly Improves the Ability of Clinicians to Diagnose Psoriatic Arthritis
por: Lai, Kuo-Lung
Publicado: (2019)

Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels
por: Zheng, Kenneth I, et al.
Publicado: (2020)

Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
por: Ahsan, Farah, et al.
Publicado: (2020)

Use of ticagrelor and the risks of pneumonia and pneumonia-specific death in patients with non-acute coronary syndrome conditions: a population-based cohort study
por: Feng, Qi, et al.
Publicado: (2021)

Non–Laboratory-Based Self-Assessment Screening Score for Non-Alcoholic Fatty Liver Disease: Development, Validation and Comparison with Other Scores
por: Lee, Yong-ho, et al.
Publicado: (2014)

Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study
por: O'Hara, Jamie, et al.
Publicado: (2020)

Predicted pro-inflammatory hs-CRP score and non-alcoholic fatty liver disease
por: Okekunle, Akinkunmi Paul, et al.
Publicado: (2023)

Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
por: Bianco, Cristiana, et al.
Publicado: (2021)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Association between the liver fat score (LFS) and cardiovascular diseases in the national health and nutrition examination survey 1999–2016
por: Lee, Chun-On, et al.
Publicado: (2021)

Prevalence of Childhood Obesity in the United States in 1999–2018: A 20-Year Analysis
por: Tsoi, Man-Fung, et al.
Publicado: (2022)

Epidemiology of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A focused literature review
por: Eguchi, Yuichiro, et al.
Publicado: (2020)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
por: Wong, Carrie R, et al.
Publicado: (2016)

Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease
por: Chao, Hsu-Wen, et al.
Publicado: (2019)

Development of a risk-stratification scoring system for predicting risk of breast cancer based on non-alcoholic fatty liver disease, non-alcoholic fatty pancreas disease, and uric acid
por: Hong, Chuntian, et al.
Publicado: (2022)

Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States
por: Le, Michael H., et al.
Publicado: (2017)

Novel multi-parametric diagnosis of non-alcoholic fatty liver disease using ultrasonography, body mass index, and Fib-4 index
por: Funada, Kei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q4qlof33suvtj8dsa92mca3urc